Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nanomix Corp (NNMX)

Nanomix Corp (NNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanomix Corp 2121 Williams Street San Leandro CA 94577 USA

www.nano.com P: 510-428-5300

Sector:

Medical

INDUSTRY GROUPING:

Medical Services

Description:

Nanomix Corporation is involved in the development of mobile, affordable, point-of-care diagnostics. The company's products are designed to impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings. Nanomix Corporation, formerly known as Boston Therapeutics Inc., is based in EMERYVILLE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 10
Enterprise Value, $K 10,470
Shares Outstanding, K 48,997
Float, K 41,329
% Float 84.35%
Short Volume Ratio 1.00
% of Insider Shareholders 15.65%
% of Institutional Shareholders 8.71%

Financials:

Annual Sales, $ 20 K
Annual Net Income, $ -12,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,810 K
EBIT, $ -8,750 K
EBITDA, $ -4,670 K

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -33.33%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/04/23
Earnings Per Share ttm -0.15
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NNMX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -61,650.00%
Debt/Equity -0.67
Price/Sales 0.06
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.24
Interest Coverage -2.00
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar